7 citations
,
September 2020 in “Journal of Cosmetic Dermatology” This study analyzed trends in consumer and physician interest in nonsurgical hair loss therapies, finding that internet searches for treatments like minoxidil and low-level laser therapy increased over time, influenced by regulations and social media.
September 2025 in “Headache The Journal of Head and Face Pain” In this critique, the authors argue that the American College of Physicians' recent guideline for migraine preventive therapy is based on a flawed analysis with low confidence levels and outdated data, failing to acknowledge newer migraine-specific therapies with stronger evidence and better tolerability.
December 2023 in “Dermatology and therapy” This study observed that patient-physician alignment on alopecia areata severity largely followed Japanese Dermatological Association criteria, yet alignment on treatment satisfaction was lower, with lack of efficacy as the main dissatisfaction reason.
April 2023 in “Journal of Investigative Dermatology” Patients and doctors often disagree on alopecia areata severity and treatment satisfaction.
January 2021 in “Social Science Research Network” This review discusses the ethical and legal challenges faced by practitioners who conscientiously object to participating in euthanasia and assisted suicide, reporting no new clinical results.
January 2021 in “SSRN Electronic Journal” This submission critiques policies on "effective referral" for euthanasia and assisted suicide, highlighting potential threats to physicians' civil liberties and suggesting revisions to uphold freedom of conscience in medical practice.
January 2011 in “Hair transplant forum international” This article addresses the role of surgical assistants in graft preparation and placement for hair restoration and reports no new clinical findings.
October 2010 in “Journal of Men's Health” Some patients may experience lasting sexual dysfunction, depression, and other side effects from 5α-reductase inhibitor therapy.
April 2007 in “Oncology Times” This research observed that both patients and primary care physicians are hesitant to fully embrace chemoprevention for cancer due to concerns over risk identification, side effects, and a lack of definitive guidance.
6 citations
,
October 2024 in “Journal of Family Medicine and Primary Care” This systematic review details monitoring and safety guidelines for primary care physicians regarding Janus kinase and tyrosine kinase 2 inhibitors used in treating inflammatory skin conditions, emphasizing their efficacy and the importance of updated knowledge due to associated box warnings and increasing use.
1 citations
,
March 2017 in “Hair transplant forum international” This article discusses the rising demand for hair transplant surgery amid a global shortage of training and fellowship programs, and it reports no new results.
September 2025 in “Cureus” This study found that dermatologists in an urban academic setting most frequently use topical corticosteroids, intralesional corticosteroids, and topical minoxidil for treating central centrifugal cicatricial alopecia, aligning with current literature recommendations on reducing inflammation.
November 2024 in “Journal of Family Medicine and Primary Care” This review highlights that 5 Alpha Reductase Inhibitors, used for treating conditions like benign prostatic hypertrophy, can cause side effects that sometimes persist after stopping the medication, urging physicians to consider these drugs as potential sources of new symptoms in patients.
December 2006 in “Cancer Epidemiology and Prevention Biomarkers” This review highlights the low uptake of tamoxifen and finasteride for cancer chemoprevention in primary care, citing various barriers and indicating a need for safer, more affordable options.
October 2021 in “Case Reports in Dermatology” This study found that there was no significant difference between patients' and physicians' assessments of androgenetic alopecia severity, despite variability in individual cases.
40 citations
,
October 2012 in “Journal of the American Academy of Dermatology” This study found that the Cutaneous Lupus Disease Area and Severity Index (CLASI) is correlated with both physician-assessed and patient-reported outcomes in cutaneous lupus erythematosus, particularly highlighting concerns about body image in visible areas.
26 citations
,
October 2019 in “JNCI Cancer Spectrum” This clinical study observed that in patients with advanced breast cancer and BRCA1/2 mutations, talazoparib provided significantly better progression-free survival, objective response, clinical benefit, and patient-reported outcomes compared to physician’s choice chemotherapy, despite common side effects like anemia and fatigue.
May 2026 in “Dermatology and Therapy” This study reports that among adults with severe alopecia areata taking ritlecitinib, 49% saw hair regrowth within 3 months, increasing to 82% after more than 6 months; treatment satisfaction also rose with longer duration, indicating sustained efficacy and improved quality of life over time.
November 2025 in “Zenodo (CERN European Organization for Nuclear Research)” This review explores the causes and management of premature greying in children, noting it may indicate underlying health issues, and emphasizes structured evaluations and treatments, particularly for nutritional deficiencies and hypothyroidism, to address hair depigmentation.
November 2025 in “Zenodo (CERN European Organization for Nuclear Research)” This review highlights concerns around premature greying in children, detailing possible links to nutritional deficiencies and other health issues, and emphasizes that structured evaluation and targeted treatment may aid in reversing the condition.
November 2025 in “World Journal of Biology Pharmacy and Health Sciences” This review reported that premature greying in children, which can indicate certain deficiencies or disorders, may be addressed through a structured evaluation and treatment targeting factors like vitamin B12 and iron deficiencies or hypothyroidism, providing a practical approach for pediatric care.
July 2025 in “SKIN The Journal of Cutaneous Medicine” This study describes characteristics and outcomes for adults initiating ritlecitinib for severe alopecia areata, highlighting increased hair regrowth and physician satisfaction with longer treatment durations, despite ongoing psychosocial impacts like embarrassment and anxiety among patients.
This study observed that premature hair graying was more prevalent among obese individuals, those with vitamin B12 and D deficiencies, smokers, and people with high stress, regardless of whether they were medical or non-medical students at a university in Saudi Arabia.
December 2023 in “European journal of dermatology/EJD. European journal of dermatology” In this study, researchers analyzed dermatologists' treatment practices for alopecia areata across five European countries, finding that topical and intralesional corticosteroids are most commonly prescribed for mild to moderate cases, while severe cases often see increased use of immunosuppressants and wigs.
June 2023 in “Dermatology and therapy” This study found that most dermatologists in the Middle East manage mild to severe alopecia areata primarily with potent topical corticosteroids and identified long-term disease control and improved efficacy as key unmet needs.
March 2020 in “Hair transplant forum international” This article reports on a Consent Agreement by the New York State Board charging Dr. Dennis Daly with professional misconduct related to unqualified and unlicensed practice.
10 citations
,
March 2004 in “Journal of the American Academy of Dermatology” The 5% minoxidil solution effectively treated hair loss with good tolerability.
8 citations
,
August 2018 in “International Journal of Dermatology” This study discusses the prevalence and ethical considerations of off-label drug use in dermatology, emphasizing differing perspectives on informed consent between patients and physicians.
2 citations
,
March 2004 in “Journal of the American Academy of Dermatology” Minoxidil 5% solution quickly improves hair growth and density with minimal side effects.
August 2024 in “Journal of Biomedical Research & Environmental Sciences” This review consolidates existing research showing that lower SHBG levels are significantly associated with adverse reproductive, metabolic, and cardiovascular outcomes, suggesting its importance as a marker in managing various health conditions.